Blog | HemaCare

CAR-T: The Designer Tumor Therapy Frontier

Dec 4, 2017 8:00:25 AM / by Stacy Matthews Branch, DVM, PhD posted in Cancer Immunology, cancer immunotherapy, CAR-T, car

0 Comments

Personalized medicine is taking new and powerful forms in the field of immunotherapy. The technology behind making customized tumor-destroying cells, thought of not long ago as science-fiction, is now a reality. [1,2] Chimeric Antigen Receptor T cells, or CAR-T cells, are designer, precision built personal immunotherapeutic agents that target an individual’s tumor. The use of CAR-T cells is a means of using the body’s own immune system arsenal to attack cancer cells.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts